Ge Qi-Yue, Zheng Chao, Song Xiao-Bin, Cong Zhuang-Zhuang, Luo Jing, Zheng Hao-Tian, Zhao Peng-Long, Wang Yan-Qing, Chen Bing-Wei, Shen Yi
School of Medicine, Southeast University, Nanjing, China.
Department of Cardiothoracic Surgery, Jinling Hospital, Nanjing, China.
CNS Neurosci Ther. 2025 Mar;31(3):e70273. doi: 10.1111/cns.70273.
Delirium is a common complication observed in intensive care units (ICUs). Propofol is one of the most widely used sedatives and is believed to be closely connected with the incidence of delirium. The study was carried out to explore the relationship between delirium and the average rate of propofol infusion.
Patients who underwent invasive mechanical ventilation (IMV) while receiving propofol from the Medical Information Mart for Intensive Care IV (MIMIC IV) database were included in the study. The primary outcome was to identify the potential risk factors for the incidence of delirium and investigate the relationship between the average rate of propofol infusion and the incidence of delirium. The secondary outcome was to further analyze the relationship by subgroup analysis. Propensity score matching (PSM) was employed to minimize bias.
A total of 16,956 patients (delirium: 5805; control: 11,151) were ultimately included in the study after PSM. The median diagnostic time of delirium was 18 h. An average propofol infusion rate ≥ 20 μg/(kgh) during the initial 18 h was found to be independently significant [OR = 1.84, 95% CI = (1.72, 1.98), p < 0.001], while an average propofol infusion rate ≤ 40 μg/(kgh) in the first hour showed no statistically significant difference in the incidence of delirium [OR = 0.95, 95% CI = (0.88, 1.02), p = 0.163]. Besides, an average propofol infusion rate ≥ 20 μg/(kg*h) was also found to be statistically significant in all the subgroup analyses.
An average propofol infusion rate ≥ 20 μg/(kg*h) during the initial 18 h was identified as an independent risk factor for delirium, suggesting that the accumulation of propofol might be associated with an increased incidence of delirium.
谵妄是重症监护病房(ICU)中常见的并发症。丙泊酚是使用最广泛的镇静剂之一,据信与谵妄的发生率密切相关。本研究旨在探讨谵妄与丙泊酚平均输注速率之间的关系。
纳入来自重症监护医学信息数据库IV(MIMIC IV)中在接受丙泊酚治疗时接受有创机械通气(IMV)的患者。主要结局是确定谵妄发生率的潜在危险因素,并研究丙泊酚平均输注速率与谵妄发生率之间的关系。次要结局是通过亚组分析进一步分析两者之间的关系。采用倾向评分匹配(PSM)以尽量减少偏倚。
经过PSM后,共有16956例患者(谵妄组:5805例;对照组:11151例)最终纳入研究。谵妄的中位诊断时间为18小时。发现在最初18小时内丙泊酚平均输注速率≥20μg/(kg·h)具有独立显著性[比值比(OR)=1.84,95%置信区间(CI)=(1.72,1.98),p<0.001],而在第一小时内丙泊酚平均输注速率≤40μg/(kg·h)时,谵妄发生率无统计学显著差异[OR=0.95,95%CI=(0.88,1.02),p=0.163]。此外,在所有亚组分析中,丙泊酚平均输注速率≥2μg/(kg·h)也具有统计学显著性。
最初18小时内丙泊酚平均输注速率≥20μg/(kg·h)被确定为谵妄的独立危险因素,提示丙泊酚的蓄积可能与谵妄发生率增加有关。